Document is current
Any future updates will be listed below
-
Authors
Nishimura, Nao
Kawano, Yawara
Yasunaga, Jun-ichirou
- License Information
-
More Information
Article History
Received: 12 November 2025
Accepted: 11 December 2025
First Online: 22 December 2025
Declarations
:
: Yawara Kawano serves as the editorial board of Clinical Clinical and Experimental Medicine.Financial interests: Yawara Kawano has received honoraria from Janssen Pharmaceuticals Inc, Bristol Myers Squibb Co., Ono Pharmaceutical, Takeda Pharmaceutical Co. Ltd., Sanofi, Pfizer and Sebia. Nao Nishimura has received honoraria from Bristol Myers Squibb Co. and Sanofi. Jun-ichirou Yasunaga has received research funding from Eisai.
: The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board and Ethics Committee of Kumamoto University.
: Informed consent was obtained from the participants included in the study.
